Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes

被引：2
|
作者：
Bober, Emilia [1 ]
Frain, Kristina [1 ]
Fotuhi, Majid [1 ]
Virgo, Jonathan [2 ]
Hindle, Edward [1 ]
Ma, Jianfei [3 ]
Luis, Joshua [1 ]
Addison, Peter [1 ]
Okhravi, Narciss [1 ]
Tucker, William [1 ]
Westcott, Mark [1 ]
Pavesio, Carlos [1 ]
Lee, Richard [1 ]
Yeung, Ian [1 ]
机构：
[1] Moorfields Eye Hosp NHS Fdn Trust, Uveitis & Scleritis Serv, London, England
[2] Guys & St Thomas NHS Fdn Trust, Med Eye Unit, London, England
[3] Whittington Hlth NHS Trust, Rheumatol Dept, London, England
来源：
EYE | 2024年 / 38卷 / 03期
关键词：
D O I：
10.1038/s41433-023-02725-3
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：628 / 630
页数：3
相关论文
共 50 条
  • [1] Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes
    Yeung, Ian
    Bober, Emilia
    Frain, Kristina
    Fotuhi, Majid
    Virgo, Jonathan
    Hindle, Edward
    Ma, Jianfei
    Addison, Peter
    Okhravi, Narciss
    Tucker, William
    Westcott, Mark
    Pavesio, Carlos
    Lee, Richard
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [2] Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes
    Emilia Bober
    Kristina Frain
    Majid Fotuhi
    Jonathan Virgo
    Edward Hindle
    Jianfei Ma
    Joshua Luis
    Peter Addison
    Narciss Okhravi
    William Tucker
    Mark Westcott
    Carlos Pavesio
    Richard Lee
    Ian Yeung
    Eye, 2024, 38 : 628 - 630
  • [3] Adalimumab in the Treatment of Refractory Non-infectious Scleritis: 18-Month Outcomes
    Bober, Emilia
    Fotuhi, Majid
    Frain, Kristina
    Luis, Joshua
    Virgo, Jonathan
    Hindle, Edward
    Diwany, Safiyya
    Ma, Jianfei
    Westcott, Mark
    Rees, Angela L.
    Tucker, William
    Addison, Peter
    Pavesio, Carlos
    Okhravi, Narciss
    Yeung, Lan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [4] ADALIMUMAB IN THE TREATMENT OF REFRACTORY NON-INFECTIOUS SCLERITIS: 18-MONTH OUTCOMES
    Bober, Emilia
    Fotuhi, Majid
    Frain, Kristina
    Luis, Joshua
    Virgo, Jonathan
    Hindle, Edward
    Diwany, Safiyya
    Ma, Jianfei
    Westcott, Mark
    Rees, Angela
    Tucker, William
    Addison, Peter
    Pavesio, Carlos
    Okhravi, Narciss
    Yeung, Ian
    EYE, 2024, 38 : 196 - 197
  • [5] Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis
    Chen, Binyao
    Yang, Shizhao
    Zhu, Lei
    Peng, Xuening
    He, Daquan
    Tao, Tianyu
    Su, Wenru
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (22)
  • [6] Adalimumab treatment in adult patients with refractory non-infectious uveitis
    Esen, Ebru
    Isik, Puren
    Sizmaz, Selcuk
    Demircan, Nihal
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 457 - 462
  • [7] Adalimumab for the treatment of refractory active and inactive non-infectious uveitis
    Lee, Jonathan T. L.
    Yates, William B.
    Rogers, Sophie
    Wakefield, Denis
    McCluskey, Peter
    Lim, Lyndell L.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2018, 102 (12) : 1672 - 1678
  • [8] Treatment of chronic non-infectious uveitis and scleritis
    Daniele, Rossi C.
    Camillo, Ribi
    Yan, Guex-Crosier
    SWISS MEDICAL WEEKLY, 2019, 149
  • [9] Adalimumab in the treatment of non-infectious uveitis
    Burek-Michalska, Alicja
    Turno-Krecicka, Anna
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (10): : 1231 - 1236
  • [10] Effectiveness of TNF-α, blockade in the treatment of refractory non-infectious scleritis: a multicentre study
    Fabiani, C.
    Sota, J.
    Sainz-de-la-Maza, M.
    Pelegrin, L.
    Emmi, G.
    Lopalco, G.
    Iannone, F.
    Vannozzi, L.
    Guerriero, S.
    Frediani, B.
    Tosi, G. M.
    Hernandez-Rodriguez, J.
    Cantarini, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (06) : 1138 - 1144
12345